Gökhan Şahin

19PUBLICATIONS
134CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 13, 2026
First-Line Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey.

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|Apr 20, 2026
Evaluating oral nutritional support and the nutritional risk scores in ICI-treated metastatic solid tumours.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Jan 08, 2026
Effect of steroid therapy on survival in patients with metastatic solid tumors experiencing immune-related adverse events.

Caner Acar, Gökhan Şahin, Haydar Çağatay Yüksel

|Dec 12, 2025
Using routine blood tests to predict severe immune-related adverse events during immune checkpoint inhibitor treatment.

Caner Acar, Fatma Pinar Açar, Gökhan Şahin

Pageof 4

Frequent Collaborators

15 joint publications

Caner Acar

15 joint publications

Haydar Çağatay Yüksel

8 joint publications

Burçak Karaca

7 joint publications

Pınar Açar